I am from India and here glivoc costs around Rs. 100,000 per dosage. this is disgustingly vulgar pricing and totally unmindful of the health of people living in developing countries. Speaking from the perspective of someone living in third world, most of the people of India cannot afford this drug and even those who can usually don't opt for it because it puts a great burden on them finanacially. Nowdays there is litigation going on over here on the patent issue of glivoc between novartis and other Indian generic manufacturers who make the same drug and sell it at a much lower price. It is one thing for a drug company to recover its costs of research and to earn profits and its another to price a drug at such an amount that majority of people are deprived of it. Then what is the use of developing newer drugs if they are out of the reach of the affected people who needs them the most. I completely agree with the author and will suggest that the drug companies should think about the needs of the people while fixing the drug prices.